| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.004 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.005 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.005 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.008 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.14 | 0.01 |